CMMB
Chemomab Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.17
−7.51%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$0.27
- EPS estimate
- -$0.15
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -212.5%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$0.15 | -$0.27 | Miss -80.00% | — |
| May 14, 2026 | -$0.04 | -$0.22 | Miss -450.00% | — |
| Mar 19, 2026 | -$0.20 | -$0.24 | Miss -20.00% | — |
| Nov 13, 2025 | -$0.20 | -$0.80 | Miss -300.00% | — |
| Aug 14, 2025 | -$0.80 | -$0.36 | Beat 55.00% | — |
| May 15, 2025 | -$0.20 | -$0.14 | Beat 30.00% | — |
| Mar 3, 2025 | -$0.20 | -$0.16 | Beat 20.00% | — |
| Nov 14, 2024 | -$0.20 | -$0.20 | In line | — |
| Aug 21, 2024 | -$0.20 | -$0.26 | Miss -30.00% | — |
| May 9, 2024 | -$0.20 | -$0.28 | Miss -40.00% | — |
| Mar 7, 2024 | -$0.40 | -$0.26 | Beat 35.00% | — |
| Nov 9, 2023 | -$0.60 | -$0.34 | Beat 43.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026